Narrative review / 2011
The Endocrine Society guideline recommends vitamin D supplementation and serum 25(OH)D testing for at-risk patients, but not routine screening for others.
An Endocrine Society Task Force developed clinical practice guidelines for evaluating, treating, and preventing vitamin D deficiency based on systematic reviews of evidence. The Task Force recommended vitamin D supplementation at suggested daily intake and tolerable upper limit levels depending on age and clinical circumstances, and treatment with vitamin D2 or vitamin D3 for deficient patients. Serum 25-hydroxyvitamin D measurement was recommended for patients at risk for deficiency. Currently, there is insufficient evidence to recommend screening individuals not at risk or prescribing vitamin D for cardiovascular protection.
- Study type
- Clinical practice guideline
- Who was studied
- Patients at risk for vitamin D deficiency and individuals across all age groups
- What was measured
- Evaluation, treatment, and prevention of vitamin D deficiency
THE PAPER
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society. J Clin Endocrinol Metab, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.